Primary Immunodeficiency Clinical Trials 2022

Browse 20 Primary Immunodeficiency Medical Studies Across 50 Cities

2 Phase 3 Trial · 109 Primary Immunodeficiency Clinics

Reviewed by Michael Gill, B. Sc.
20 Primary Immunodeficiency Clinical Trials Near Me
Houston, TX
Houston, TX
Centennial, CO
Charleston, SC
More Trial Locations
An interactive map to display trial locations for Houston Methodist Hospital, Texas Children's Hospital, Immunoe Research Centers, Medical University of South Carolina, and 79 more locations.
Most Popular References for Primary Immunodeficiency Clinical Trials
Frequency
Citation
1
Botox (onabotulinumtoxinA) Product Information: http://www.botoxcosmetic.com/botox_physician_info/Clinical_Information.aspx http://www.clinicaltrials.gov/ct2/show/NCT01313767?term=Botox+pi&rank=1
Top Hospitals for Primary Immunodeficiency Clinical Trials
Top Treatments for Primary Immunodeficiency Clinical Trials
Treatment Name
Active Primary Immunodeficiency Clinical Trials
All Time Trials for Primary Immunodeficiency
First Recorded Primary Immunodeficiency Trial
Trials
Norovirus -specific T-cell (NST) therapy
1
1
2022
Top Cities for Primary Immunodeficiency Clinical Trials
City
Active Primary Immunodeficiency Clinical Trials
Top Active Site for Primary Immunodeficiency Clinical Trials
Trial List
Milwaukee, Wisconsin
5
Medical College of Wisconsin/Children's Hospital of Wisconsin
Most Recent Primary Immunodeficiency Clinical Trials
Phase 3 Primary Immunodeficiency Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Pediatric Primary Immunodeficiency Clinical Trials
Senior Friendly Primary Immunodeficiency Clinical Trials
Recently Completed Studies with FDA Approved Treatments for Primary Immunodeficiency
Treatment
Year
Mechanism of Action
Sponsor
Active Primary Immunodeficiency Clinical Trials
IVIG-PEG
2020
Human immunoglobulin G
Grifols Therapeutics LLC
4
CUTAQUIG
2019
Human immunoglobulin G
Octapharma
4
HYQVIA
2017
Hyaluronidase (human recombinant) + Human immunoglobulin G
Baxalta now part of Shire
4

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 19th, 2021

Last Reviewed: August 10th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.